These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1889377)

  • 1. Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats.
    Dalvi RR; Dalvi PS
    Drug Chem Toxicol; 1991; 14(1-2):219-29. PubMed ID: 1889377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of piperine administered intragastrically and intraperitoneally on the liver and liver mixed-function oxidases in rats.
    Dalvi RR; Dalvi PS
    Drug Metabol Drug Interact; 1991; 9(1):23-30. PubMed ID: 1893751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of curcumin, capsaicin, and piperine on the rat liver drug-metabolizing enzyme system in vivo and in vitro.
    Suresh D; Srinivasan K
    Can J Physiol Pharmacol; 2006 Dec; 84(12):1259-65. PubMed ID: 17487234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of hepatic cytochrome P-450 in C57 BL/10 and DBA/2 mice by isosafrole and piperonyl butoxide. A comparative study with other inducing agents.
    Fennell TR; Sweatman BC; Bridges JW
    Chem Biol Interact; 1980 Aug; 31(2):189-201. PubMed ID: 7389009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of piperine with rat liver microsomes.
    Bhat BG; Chandrasekhara N
    Toxicology; 1987 Apr; 44(1):91-8. PubMed ID: 3564048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of purified and technical piperonyl butoxide on drug-metabolizing enzymes and ultrastructure of rat liver.
    Goldstein JA; Hickman P; Kimbrough RD
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):444-58. PubMed ID: 4767580
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo inhibition of pulmonary cytochrome P450 activities by piperine, a major ingredient of piper species.
    Reen RK; Singh J
    Indian J Exp Biol; 1991 Jun; 29(6):568-73. PubMed ID: 1889831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive effect of piperine on mitochondrial TCA cycle and phase-I and glutathione-metabolizing enzymes in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice.
    Selvendiran K; Thirunavukkarasu C; Singh JP; Padmavathi R; Sakthisekaran D
    Mol Cell Biochem; 2005 Mar; 271(1-2):101-6. PubMed ID: 15881660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
    Atal CK; Dubey RK; Singh J
    J Pharmacol Exp Ther; 1985 Jan; 232(1):258-62. PubMed ID: 3917507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperine effects on the expression of P4502E1, P4502B and P4501A in rat.
    Kang MH; Won SM; Park SS; Kim SG; Novak RF; Kim ND
    Xenobiotica; 1994 Dec; 24(12):1195-204. PubMed ID: 7771106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic glutathione and hepatotoxicity: effects of cytochrome P-450 complexing compounds SKF 525-A, L-alpha acetylmethadol (LAAM), norLAAM, and piperonyl butoxide.
    James RC; Harbison RD
    Biochem Pharmacol; 1982 May; 31(10):1829-35. PubMed ID: 7104014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subchronic effects of piperonyl butoxide on carcinogen metabolism in hamster liver.
    Friedman MA
    Bull Environ Contam Toxicol; 1979 Apr; 21(6):815-21. PubMed ID: 465762
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition by piperonyl butoxide of phenobarbital mediated induction of mouse liver microsomal enzyme activity.
    Friedman MA; Couch DB
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):515-26. PubMed ID: 4852466
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of piperonyl butoxide on halothane hepatotoxicity and metabolism in the hyperthyroid rat.
    Smith AC; Roberts SM; Berman LM; Harbison RD; James RC
    Toxicology; 1988 Jun; 50(1):95-105. PubMed ID: 3388433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-function oxidase system induction and propylene hepatotoxicity.
    Osimitz TG; Conolly RB
    J Toxicol Environ Health; 1985; 15(1):39-49. PubMed ID: 2984438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal exposure to cadmium alters the responses of the hepatic monooxygenases to phenobarbital and to cadmium in adult male rats.
    Virgo BB; Virgo NS
    J Pharmacol Exp Ther; 1984 Dec; 231(3):700-4. PubMed ID: 6502523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of cytochrome P-450 by the drug methoxsalen.
    Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D
    J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.
    Bhardwaj RK; Glaeser H; Becquemont L; Klotz U; Gupta SK; Fromm MF
    J Pharmacol Exp Ther; 2002 Aug; 302(2):645-50. PubMed ID: 12130727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hepatic ischemia-reperfusion injury on the hepatic mixed function oxidase system in rats.
    Lindstrom TD; Hanssen BR; Bendele AM
    Mol Pharmacol; 1990 Dec; 38(6):829-35. PubMed ID: 2250663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.